BioProcess Intl. retweeted
#BiotechWeekBoston #BWB2022 Marketing news just in: after a major m&a spree, pharma services firm Aceto has rebranded and unified its 11 businesses under the name Actylis
BioProcess Intl. retweeted
I enjoyed this panel discussion with @EytanAbraham1, Justin Skoble and Patti Seymour. Thanks for inviting me. #BIO2022 @locanabio
Happening now: Therapeutic Cell and Gene Therapy Modalities - Business and Manufacturing Strategies Impacting the Decision to Develop One Therapy Type vs. Another at the #BPITheater at #bio2022 booth 919
BioProcess Intl. retweeted
Our president and CEO Eric Dube speaks @BIOConvention about how having a diverse organization and a stated intent around #DEI helps bring medical innovation to patients that need it. #BIO2022 #InRareForLife
#DEI is "not just about what happens in a company," says Eric Dube of @TravereRare--watch as he explains #BIO2022
BioProcess Intl. retweeted
Day 2 of the @BioProcessIntl BPI Theater at #BIO2022 kicks off with a presentation from @CatalentPharma
BioProcess Intl. retweeted
Are you at #BIO2022 and interested in networking with like-minded professionals? Join us on the BIO Convention Exhibit Hall floor for WIB's Speed Networking today at 2:00 p.m. PDT! Walk-ins are welcome! Learn more: ow.ly/w2ap50JvxnG
#WomenInBio #WIBatBIO2022
BioProcess Intl. retweeted
"COVID did provide the world with a front row seat to our potential – and we answered resoundingly." -@DrMichelleBIO #BIO2022 #BIOUnbound
BioProcess Intl. retweeted
Our own Graziella Piras is going to be sharing Sept. 7 as part of @BioProcessIntl's 'Ask the Expert' series. Sign up so you can hear her speak about cell culture media analysis: bit.ly/2UXpHaY
BioProcess Intl. retweeted
Register for day 2 of BPI Theater where our R&D Director, Marc Hummersone, will join @Dan5tanton for his first BioProcess Insider Interview! @BioProInsider
This Wednesday and Thursday, we're airing an encore presentation of our BPI Theater at BIO stage, including 15 webcasts and interviews focusing on the newest emerging therapies and technologies being developed for their rapid manufacture.
Register today: spr.ly/6016ybVvO
BioProcess Intl. retweeted
The latest Biotech Week Boston Newsletter! news.biotechweekboston.com @RobDaMosCutt @audiumcp @BioProcessIntl #digitalhealth #mhealth
BioProcess Intl. retweeted
“By combining #science, #technology, #engineering, and networking, the company is working to provide a timely and efficient pathway for advanced therapies to reach patients at lowered costs.” Our CEO, Vered Caplan, sat down with @BioProcessIntl - bit.ly/3AkZCTl
BioProcess Intl. retweeted
We recently talked with @BioProcessIntl about our new polymer dyes.
"Due to the brighter signal, SuperNova v428 is also better for discriminating between negative and positive cell populations with significantly less noise."
Brice Ezzouaouy shares more: becls.co/3pqXeoU
BioProcess Intl. retweeted
Another great publication by @KamalRashid8 in @BioProcessIntl. Changing the way we think about training in #biotech/#biopharma relative to global public health— and setting the tone for the future #biomanufacturing workforce.
📝Read the full article here: bit.ly/33OLen6
BioProcess Intl. retweeted
Cellares CEO & cofounder Fabian Gerlinghaus @gerlinghausf discusses their Cell Shuttle automated cell therapy processing system--and why the world needs it--with @BioProcessIntl.
bioprocessintl.com/manufactu…
BioProcess Intl. retweeted
In case you missed our #AsktheExpert webinar, New Data: A Better Way to Run CHO Cell Culture Experiments, with Culture's VP of Ops Deborah Pascoe, PhD, read this recap from @BioProcessIntl or watch the webinar on demand! hubs.ly/H0LqG240
#bioprocessing #bpi #cellculture
BioProcess Intl. retweeted
In the latest example of pandemic-related collaboration, @Novartis is prepping to make the drug substance for Roche’s Actemra (tocilizumab), currently being investigated as a treatment for severe #COVID19 -associated pneumonia buff.ly/3tnZLkH
BioProcess Intl. retweeted
Please join us for this free Ask The Expert webcast with @BioProcessIntl on Manufacturing a Recombinant #Retrovirus: Downstream #Purification Process Development through #GMP Implementation with Mark Fitchmun, CEO of Somatek
Register: ow.ly/WIeV50ElhhE
BioProcess Intl. retweeted
We conducted a global survey of professionals working in #oligonucleotide, #peptide, & #mRNA therapeutics to find out what major changes occurred across the sector as a result of the COVID-19 pandemic. This exclusive report reveals the story so far.
spr.ly/6013H0qPl
BioProcess Intl. retweeted
Singapore sets Sanofi’s vaccine spend at $2bn+ - After investing heavily to develop sites in France and Canada, Sanofi will now spend €400 million to establish a vaccine production center in Singapore.
From @BioProInsider
buff.ly/324k0bn
BioProcess Intl. retweeted
Our own Mike Paglia, COO of Basecamp, sat down with @GarethMacdonald at @BioProcessIntl to talk about the challenges facing cell and gene therapy manufacturing and Elevate's right from the start approach. Read more here: bioprocessintl.com/bioproces…
BioProcess Intl. retweeted
Could aerospace & automotive provide the answers in #CellandGeneTherapy?
An interesting read from @CobraBiologics highlighting the opportunities that #COVID19 provides in addressing the skills shortage.
@BioProcessIntl article: bit.ly/3wFVdsf































